RE:RE:Exactly How Does TLD1433 Kill Cancer Cells?Whether Dr. McFarland gets a grant or not has zero effect on the trial. She does not work for Theralase - Theralase just has the rights to use the photodynamic compounds she has already created and Theralase will have those rights for many years to come. Whatever Dr. McFarland decides to do, Theralase's current and future trials with TLD1433, Rutherrin and thouands of her other photosensitizers, will remain unaffected.
However, if she does discover the exact mechanism by which TLD1433 destroys cancer this could lead to the creation of even more effective photosensitizers, and Theralase would also have the exclusive right to use them.
I have no doubt that Theralase will commercialize it's treatment for bladder cancer as soon as it is humanly possibly, to the benefit of both the company and it's shareholders.
steamfitter wrote: In my opinion and believe this will extend the time period for TLT running out the clock. In my opinion I also believe that it keeps the doctor and lab financed for the next four years. No need then to push this into comercial production for bladder cancer.
Everyone happy but the stock holders in my opinion.
We need answers now as to the results of phase 2. If it works great if it do not. Lets find out.